This can inhibit the activity of the transcription factor SREBP2 in intestinal germinal center B cells, suppressing their differentiation into IgA plasma cells and reducing the production of IgA, and consequently impairing antigen-specific IgA responses during intestinal infections (12, 49). The gene discussed is CD79A; the disease is digestive system infectious disorder.